Personalizing prostate cancer education for patients using an EHR-Integrated LLM agent.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 41413170.
- Also identified by DOI 10.1038/s41746-025-02166-0 and PMC identifier 12714722.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Cancer patients often lack timely education and personalized support due to clinician workload. This quality improvement study develops and evaluates a Large Language Model (LLM) agent, MedEduChat, which is integrated with the clinic's electronic health records (EHR) and designed to enhance prostate cancer patient education. Fifteen non-metastatic prostate cancer patients and three clinicians recruited from the Mayo Clinic interacted with the agent between May 2024 and April 2025. Findings showed that MedEduChat has a high usability score (UMUX = 83.7/100) and improves patients' health confidence (Health Confidence Score rose from 9.9 to 13.9). Clinicians evaluated the patient-chat interaction history and rated MedEduChat as highly correct (2.9/3), complete (2.7/3), and safe (2.7/3), with moderate personalization (2.3/3). This study highlights the potential of LLM agents to improve patient engagement and health education.